Cover Image

Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis

Purpose: To conduct a systematic review and network meta-analysis (NMA) to compare the efficacy of currently available combination therapies in patients with metastatic hormone-sensitive prostate cancer (mHSPC).Methods: Qualified publications were searched in the PubMed, Embase, and Cochrane CENTRAL...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tengteng Jian (Author), Yang Zhan (Author), Ying Yu (Author), Kai Yu (Author), Rui Hu (Author), Jixue Wang (Author), Ji Lu (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systemic triplet therapy for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis
by: Tengteng Jian, et al.
Published: (2022)

Sequential versus concomitant treatment of androgen receptor signaling inhibitors and docetaxel for metastatic hormone-sensitive prostate cancer: an network meta-analysis
by: Chun Xing Li, et al.
Published: (2024)

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer
by: Huina Wu, et al.
Published: (2024)

Assessment of androgen receptor signaling inhibitors therapy in metastatic hormone-sensitive prostate cancer
by: Jukapun Yoodee, et al.
Published: (2022)

Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis
by: Peng-Fei Zhang, et al.
Published: (2021)

Hormonal therapy in metastatic prostate cancer: current perspectives and controversies
by: Manish Garg, et al.
Published: (2013)

Age and Prostatic Volume: The Prognosis for Benign Prostatic Hyperplasia
by: Dr. Afsheen Khan, et al.
Published: (2024)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
by: Karli Sreenivasulu, et al.
Published: (2019)

Docetaxel in hormone-sensitive advanced prostate cancer; GENESIS-SEFH evaluation reporta
by: Emilio Jesús Alegre del Rey, et al.
Published: (2017)

Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)
by: Huan Xu, et al.
Published: (2022)

Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
by: Xin Wang, et al.
Published: (2020)

Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone
by: Guanxing Sun, et al.
Published: (2021)

Tannins, novel inhibitors of the volume regulation and the volume-sensitive anion channel
by: Tsiferova N.A, et al.
Published: (2019)

Profile of Relugolix in the Management of Advanced Hormone-Sensitive Prostate Cancer: Design, Development, and Place in Therapy
by: Tatenuma T, et al.
Published: (2023)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
by: Ebenezer Abotsi, et al.
Published: (2022)

Evaluation of metastatic potential of prostate cancer
by: Yoshitomo Chihara, et al.
Published: (2011)

Metastatic prostate cancer masquerading as lymphangioma circumscriptum
by: Caroline A. Gerhardt, BS, et al.
Published: (2022)

The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024)

Effect of preoperative prostate volume on the improvement of lower urinary tract symptoms in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
by: Behzad Lotfi, et al.
Published: (2020)

A rare presentation of prostate adenocarcinoma metastatic to the maxilla
by: Venkata S Prathi, et al.
Published: (2017)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015)

Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease
by: Petcu Eugen, et al.
Published: (2012)

The effect of Iranian licorice root extract on prostate volume and clinical signs of disease in patients with benign prostatic hyperplasia
by: Azam Taheri
Published: (2023)

Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis
by: Takashi Matsushima, et al.
Published: (2018)

177Lu-PSMA-617 for metastatic prostate cancer in India
by: Aruni Ghose, et al.
Published: (2024)

Anti-metastatic effect of taraxasterol on prostate cancer cell lines
by: Morteza Movahhed, et al.
Published: (2023)

Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
by: Becich Michael J, et al.
Published: (2011)

An Unusual Case of Acute Appendicitis due to Metastatic Prostatic Adenocarcinoma
by: Numbereye Numbere, et al.
Published: (2020)

Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma
by: David Kato MD, et al.
Published: (2014)

Volume matters and intensification is needed: emerging trends in the management of advanced prostate cancer
by: Iris Y Sheng, et al.
Published: (2021)

Comparing efficacy of first-line treatment of metastatic castration resistant prostate cancer: a network meta-analysis of randomized controlled trials
by: Yang Liu, et al.
Published: (2023)

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis
by: Junru Chen, et al.
Published: (2022)

Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
by: Parwani Anil V, et al.
Published: (2007)

Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer
by: N. A. Avxentyev, et al.
Published: (2019)

Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
by: Nora A. Alkhudair
Published: (2019)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
by: Faiza Naseer, et al.
Published: (2021)

Metastatic prostate adenocarcinoma to the brain - a clinicopathologic analysis of 21 cases
by: Namra Ajmal, et al.
Published: (2024)

A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer
by: Leila Moosavi MD, et al.
Published: (2019)

The Prognostic Value of Post-Void Residual Urine Volume, Abdominal Prostate and Transrectal Prostate Ultrasound for Complication of Benign Prostate Hyperplasia: A Case Report Sonographic Analysis
by: Ifeanyi Nicholas Malu
Published: (2019)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019)